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Critical Roles for the Bcl-3 Oncoprotein
in T Cell±Mediated Immunity, Splenic
Microarchitecture, and Germinal Center Reactions
Guido Franzoso,1 Louise Carlson,1, 7 expression of Bcl-3 most likely contributed to B cell
tumorigenesis, although potential mechanisms remainTanya Scharton-Kersten,2, 7 Elizabeth W. Shores,4, 7
unknown.Suzanne Epstein,5 Alexander Grinberg,3 Tom Tran,4
Bcl-3 features a central domain with seven ankyrinEmily Shacter,4 Antonio Leonardi,1 Miriam Anver,6
repeats whose sequences are most similar to thosePaul Love,3 Alan Sher,2 and Ulrich Siebenlist1
present in IkB family proteins (Hatada et al., 1992). Like1Laboratory of Immunoregulation
IkB proteins, Bcl-3 physically interacts with NF-kB pro-2Laboratory of Parasitic Diseases
teins, primarily via its ankyrin domain (Wulczyn et al.,National Institute of Allergy and Infectious Diseases
1992; Bours et al., 1993; Franzoso et al., 1993). However,3Laboratory of Molecular Genetics
unlike IkB proteins, Bcl-3 preferentially interacts withNational Institute of Child Health
p50 or p52 homodimers (Franzoso et al., 1992, 1993;and Human Development
Wulczyn et al., 1992; Bours et al., 1993; Fujita et al.,National Institutes of Health
1993; Naumann et al., 1993; Nolan et al., 1993). These4Division of Hematologic Products
homodimers do not readily transactivate kB-dependent5Division of Cellular and Gene Therapies
reporters, because p50 and p52 are the only membersCenter for Biological Evaluation and Research
of the family of NF-kB polypeptides that do not harborFood and Drug Administration
known transactivation domains (for review see BaeuerleBethesda, Maryland, 20892
and Henkel, 1994; Siebenlist et al., 1994; Verma et al.,6Pathology/Histotechnology Laboratory
1995; Baldwin, 1996). Instead,p50 homodimerscompet-Science Applications International Corporation
itively inhibit transactivation mediated by p65-con-and National Cancer Institute
taining NF-kB complexes, and cotransfection of Bcl-3Frederick Cancer Research and Development Center
can reverse the inhibition, apparently by removing p50Frederick, Maryland 21702
homodimers from DNA (Franzoso et al., 1992, 1993; In-
oue et al., 1993). In this scenario, Bcl-3 facilitates trans-
activation, in contrast with the usual inhibitory functionsSummary
of the other known members of the IkB family.
Bcl-3 can also function as a potent coactivator withChromosomal translocations of bcl-3 are associated
p52 homodimers (Bours et al., 1993; Chang et al., 1995).with chronic B cell lymphocytic leukemias. Previously,
Bcl-3 was shown to transactivate a kB-dependent re-we have shown that Bcl-3, a distinct member of the
porter in the presence of p52 homodimers, apparentlyIkB family, may function as a positive regulator of NF-
as a result of ternary complex formation on DNA and
kB activity, although its physiologic roles remained
because of transactivation domains present in Bcl-3. Inunknown. To uncover these roles, we generated Bcl-
this series of experiments, exogenous expression of p503-deficient mice. Mutant mice, but not their littermate
homodimers with Bcl-3 did not lead to significant trans-controls, succumb to T. gondii owing to failure to
activation, but in another study, which differed in experi-mount a protective T helper 1 immune response. Bcl-
mental details, this combination led to modest levels of3-deficient mice are also impaired in germinal center
transactivation (Fujita et al., 1993). There is evidence toreactions and T-dependent antibody responses to
suggest that the functional interaction of Bcl-3 with p50
influenza virus. The results reveal critical roles for
or p52 homodimers is modulated by phosphorylation,
Bcl-3 in antigen-specific priming of T and B cells. Al-
which may differ with cells and conditions (Nolan et
tered microarchitecture of secondary lymphoid or- al., 1993; CaamanÄ o et al., 1996). In any case, Bcl-3 is
gans in mutant mice, including partial loss of B cells,
implicated in transactivation of kB-dependent reporters,
may underlie the immunologic defects. The implied
differentiating this protein from other members of the
role of Bcl-3 in maintaining B cells in wild-type mice
IkB family. Despite these insights into possible mecha-
may related to its oncogenic potential. nisms of action, the biologic contexts in which Bcl-3
functions are still unknown. Analyses of transgenic mice
carrying a bcl-3 transgene under the control of the lck
Introduction promoter, which directs expression in thymocytes, also
did not reveal a biologic function for Bcl-3 (CaamanÄ o et
bcl-3 was first identified as a gene involved in recurrent al., 1996).
translocations in certain cases of B cell chronic lympho- To gain physiologic insights into the role of Bcl-3,
cytic leukemias (B-CLL) (Ohno et al., 1990). Reciprocal we generated Bcl-3 null mutant mice by targeted gene
translocations of bcl-3 with the immunoglobulin locus disruption. Such mice appeared to develop normally,
resulted in higher and possibly inappropriate expression but exhibited select defects upon immunologic chal-
of this gene due to the influence of a now juxtaposed lenge. Bcl-3-deficient animals dramatically failed in re-
immunoglobulin enhancer. Since the structure of the sisting infection with Toxoplasma gondii, an intracellular
encoded protein was apparently unchanged, abnormal parasite, owing to lack of a protective T helper 1±like
response. Bcl-3-deficient animals were impaired in ger-
minal center formation and in formation of a proper mi-7 These authors made equally significant contributions and are listed
in alphabetical order. croarchitecture in spleen and lymph nodes. These mice
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Figure 1. Targeted Disruption of the bcl-3
Gene
(A) The targeting vector, partial exon±intron
structure of the bcl-3 gene locus, and mu-
tated allele after homologous recombination
of the targeting vector are shown. Probes
used and fragments detected in Southern
blots are indicated. Abbreviations are as fol-
lows: kbp, kilobase pairs; neo, neomycin; tk,
thymidine kinase; hsv, herpes simplex virus;
B, BamHI; S, SmaI; N, NotI; H, HindIII; X, XbaI.
(B) Southern blot analyses of ES cells (left
panel) and of the offspring from the resulting
mice heterozygous for the mutated allele
(progeny; right panel). Correct homologous
recombination in ES cells generates a new
XbaI restriction fragment B (6.2 kb) in addition
to the wild-type allele-derived fragment A
(12.7 kb), and both were detected with probe
a (a 0.45 kb SmaI fragment of BS-Not3). Cor-
rect insertion of the targeting vector was con-
firmed with additional analyses (data not
shown). bcl-3 1/2, 1/1, and 2/2 mice in the
offspring were identified with probe b, a 0.24
kb NotI±EcoRV fragment of bcl-3 cDNA,
which hybridizes to the BamHI fragments C
(wild type) and D (mutant) (progeny panel).
(C) Northern blot analysis of bcl-3 1/1 (odd
lanes) and 2/2 mice (even lanes) for bcl-3
mRNA expression (top panel; bottom panel
shows expression of glyceraldehyde 3-phos-
phate dehydrogenase [GAPDH] as a control).
were also defective in proper antibody responses to interaction with NF-kB target complexes (see Introduc-
influenza virus. Furthermore, a partial loss of B cells was tion). Two out of six independently derived bcl-3 mutant
noted. Bcl-3 may therefore contribute to the survival of ES clones (B28 and B52) (analysis of clone B28 is shown
B cells, which may relate to its oncogenic potential. The in Figure 1B, left panel) were microinjected into C57Bl/
data suggest a role for Bcl-3 in select antigen-specific 6 blastocysts, and resulting male chimeras were bred
T and B cell responses and thus provide defined physio- to C57Bl/6 females to generate mice heterozygous for
logic contexts in which this protein is critical. the mutated allele (via germline transmission). Matings
of heterozygous animals, which displayed no obvious
abnormalities, then generated bcl-3 1/2, 1/1, and 2/2
mice (Figure 1B, right panel). Both mutant ES cell linesResults
allowed for germline transmission, and the two indepen-
dently derived lines of mice were indistinguishable in allTargeted Disruption of the bcl-3 Gene Locus
subsequent experiments.We generated mice lacking functional Bcl-3 by targeted
As expected, Northern blot analysis of tissues ob-disruption of the bcl-3 locus in embryonic stem (ES)
tained from bcl-3 2/2 mice failed to reveal any transcriptcells. Upon homologous recombination of the targeting
when probed with a cDNA fragment encompassing theconstruct, most of the ankyrin repeat±encoding exons
deleted exons of bcl-3 (Figure 1C). In wild-type animals,of bcl-3 were replaced by a neomycin cassette (Figure
1A), thus eliminating the domain responsible for physical bcl-3mRNA was detectable inmost tissues at low levels,
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Figure 2. Absence of Germinal Centers and
Reduction of the B Cell Compartment in bcl-3
2/2 Mice
(A) FCM analysis of splenocytes from 6-week-
old bcl-3 2/2 and 1/1 mice. Thy1.2±red
670 versus B220-PE two-color profiles are
diplayed. Numbers in the quadrants reflect
the percentage of total spleen cells in that
quadrant.
(B) Absence of distinct B cell follicular organi-
zation and germinal centers in spleens of an
unchallenged, 8.5-week-old bcl-3 2/2 mouse
and a 1/1 littermate control. Bouin-fixed,
paraffin-embedded sections were stained
with hematoxylin andeosin (HE) orprocessed
with anti-CD3 or anti-B220 antibodies, as
indicated.
consistent with a prior report (Nolan et al., 1993). How- The reduced B:T cell ratio in Bcl-3 null mice was con-
firmed by immunohistochemical analyses for B and Tever, high levels of expression were quite restricted to
cells in paraffin-embedded tissue sections of spleen andcertain tissues, in particular lymph nodes and spleen.
lymph nodes. The B220-positive B cell compartment
was reduced in size in unchallenged, Bcl-3-deficient
B Cell Population, Germinal Center Formation, animals as compared with their littermate controls.
and Antibody Responses These mice largely lacked the well-organized, densely
Homozygous bcl-3 2/2 mice were born with the ex- packed B cell follicles that were readily observed in
pected frequency, developed normally, and showed no spleens and lymph nodes of littermate controls (Figure
gross macroscopic abnormalities, except for variably 2B; spleen sections shown only; compare B220 1/1
hypoplastic lymph nodes (data not shown). Flow cyto- with 2/2). Thus, Bcl-3-deficient mice exhibited a partial
metric (FCM) analyses revealed a consistent reduction loss of follicular B cells. Immunologic challenge with
in the B:T cell ratio of Bcl-3-deficient animals in spleens influenza virus or T. gondii led to further progressive loss
(Figure 2A), as well as in blood and lymph nodes (data of B cells from secondary lymphoid organs in mutant but
not shown). No significant additional abnormalities were not littermate control mice (data not shown; see below).
apparent by FCM analyses in expression of the following It is possible that Bcl-3 has a role in maintaining the B
surface markers in spleen, lymph nodes, bone marrow, cell population.
and/or thymus of bcl-3 2/2 mice: CD3, CD4, CD8, The stained sections also revealed the presence of
abTCR, Thy1.2, B220, CD28, CD44, HSA, Sca1, c-kit, some germinal centers within the B cell follicular areas
CD25, CD69, NK1.1, GR-1, immunoglobulin D (IgD), IgM, of the littermate controls, which were most likely gener-
ated in response to environmental antigens (visible asCD5, CD45RB, I-Ab, and CD40 (data not shown).
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Figure 3. Impaired Formation of Germinal Centers in Spleens of bcl-3 2/2 Mice
We challenged 10- to 14-week-old bcl-3 2/2 mice and 1/1 and 1/2 control mice (only 1/1 is shown) by intraperitoneal injection of 100 mg
of alum-adsorbed TNP-KLH. Frozen sections of spleens were obtained 8 or 17 days after injection or from uninjected animals and stained
with anti-CD35 antibodies, PNA, or FDC-M1 antibodies, respectively. Stained cryosections from a representative pair of littermates are shown.
a lighter-staining center surrounded by a darker ring, for germinal center reactions were completely lacking
in the mutant mice, consistent with the data in Figurewhich was evident with both hematoxylin and eosin and
B-220; Figure 2B, 1/1). Such centers were not noted 2. Both CD35-positive cell clusters and follicular den-
dritic cell (FDC) clusters, which are normally associatedin secondary lymphoid organs of Bcl-3-deficient animals
(Figure 2B, 2/2; only spleen shown), which may be with germinal centers (Schubart et al., 1996), could not
be observed in Bcl-3 null mutant mice, but were readilyrelated to the apparent impairment in B cell follicular
structure. The inability of Bcl-3 null mutant mice to gen- detected in littermate controls (Figure 3; CD35 and
FDCM1; compare 1/1 with 2/2 mice).erate germinal centers was even more evident when
mice were deliberately challenged with influenza virus Given the defect in germinal center formation, we
tested the ability of bcl-3 2/2 animals to mount a hu-or with the parasite T. gondii, since these centers were
now frequently observed in littermate controls (data moral, T-dependent response to a physiologic chal-
lenge, infection with influenza virus. bcl-3 2/2 micenot shown).
While impaired in full germinal center reactions, Bcl- developed serum levels of Flu-specific IgM antibodies
equivalent to levels measured in littermate control ani-3-deficient mice may not be completely blocked in every
aspect of these reactions, at least not when animals mals (Figure 4). The mutant mice did, however, exhibit
a significantly impaired IgG2a antibody response, thewere injected with high amounts of TNP±keyhole lim-
pet hemocyanin (TNP-KLH) antigen adsorbed to alum. dominant switched immunoglobulin isotype generated
in response to influenza virus in wild-type mice (Coute-Immunostaining of splenic cryosections revealed the
presence of some peanut agglutinin (PNA)-staining cell lier et al., 1987) (Figure 4). The mutant mice did not
generate any significant levels of other isotypes (dataclusters in challenged Bcl-3-deficient animals. PNA is
considered a marker for germinal center B cells (Mac- not shown). The remaining lower levels of Flu-specific
IgG2a seen in some mice lacking Bcl-3 could be dueLennan, 1994). Nevertheless, the numbers of these clus-
ters were significantly lower than those seen in littermate to generation of some switched antibodies outside of
germinal centers (see Discussion). Despite the impairedcontrols (Figure 3; PNA; compare 1/1 with 2/2 mice).
Apart from the PNA marker, however, other indicators humoral response to influenza virus, serum titers for all
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Figure 4. Defective Antibody Response in
bcl-3 2/2 Mice
bcl-3 2/2 mice produce reduced amounts of
IgG2a (right panel) butnormal amounts of IgM
(left panel) antibodies after infection with in-
fluenza virus. Antibody titers prior to and 27
days after infection are shown for each geno-
type. Other influenza-specific antibody iso-
types were at low levels even in control mice
(data not shown). One of two independent
experiments is shown. IgG2a anti-influenza
titers differed significantly (p , 0.001) among
the three groups (1/1, 1/2, and 2/2) by
one-way analysis of variance. Pairwise com-
parisons identified the 2/2 mice as signifi-
cantly different from each of the other groups,
while 1/1 mice did not differ from 1/2 mice.
immunoglobulin isotypes were within normal range in marginal metallophilic macrophages (MMM) could be
uniquely identified at the inner margin of the MZ withmutant mice (data not shown).
an anti-sialoadhesin receptor antibody (data not shown)
or with the MOMA-1 antibody (Leenen et al., 1994) (Fig-The Microarchitecture of Spleens
To probe for defects that may underlie impaired germinal ure 5, 1/1). In Bcl-3-deficient animals, in contrast,
MMMs were dramatically reduced in numbers, and theycenter formation or antibody responses in Bcl-3-defi-
cient animals, we further analyzed the splenic microar- no longer formed a continuous ring of cells (Figure 5,
2/2; staining with anti-sialoadhesin antibodies gavechitecture by immunostaining with various cell markers.
While the B cell follicular zones appeared to be less similar results). Even more striking was the virtual ab-
sence of cells staining positive with ER-TR9 in mutantwell organized (see above), the T cell zones of spleen
appeared grossly normal (see Figure 2B, CD3), including mice, while this antibody was clearly staining cells in
littermate controls (Figure 5). ER-TR9 is the only uniquethe presence of interdigitating dendritic cells (data not
shown). The marginal zone (MZ) represents a third com- antibody marker for marginal zone macrophages (MZM),
which form a ring of cells in the outer portion of the MZpartment of splenic white pulp, where distinct macro-
phage populations reside. In littermate control animals, (Leenen et al., 1994). The finding suggests that MZMs
Figure 5. Altered Microarchitecture in Spleens
of bcl-3 2/2 Mice
Splenic cryosections were derived from the
same group of bcl-3 2/2 and 1/1 mice that
was used for Figure 3. Sections were stained
with monoclonal antibodies specific to red
pulp macrophages (RPM; F4/80), marginal
metallophilic macrophages (MMM; MOMA-1),
or marginal zone macrophages (MZM; ER
TR-9), as indicated. Similar results were ob-
tained with spleens from unchallenged ani-
mals (data not shown).
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with inflammation of multiple tissues (data not shown).
Near time of death, the thymus became necrotic and
secondary lymphoid organs nearly acellular; at this late
point, T cells were also lost from secondary lymphoid
organs, which occurred on top of the prior loss of B
cells (data not shown; see above). The dramatic deaths
of the null mutant mice, but not their littermate controls,
documents a unique requirement for Bcl-3 in mounting
a protective immune response to a natural pathogenic
challenge; Bcl-3 was therefore essential for the survival
of the host.
Interferon-g (IFNg) is a critical effector, helper type 1
cytokine for the protective immune response toT. gondii
Figure 6. bcl-3 2/2 Mice Succumb to T. gondii Infection (Gazzinelli et al., 1993; Scharton-Kersten et al., 1996).
bcl-3 2/2 mice and 1/2 and1/1 littermateswere injected intraperi- During the first week of infection, soluble tachyzoite
toneally with approximately 20 cysts of the avirulent T. gondii strain antigen (STAg) (Toxoplasma antigen preparation; Hakim
ME49 (initially provided by Dr. J. Remington, Palo Alto Research
et al., 1991) treated splenocytes from mutant mice andFoundation), as detailed previously (Scharton-Kersten et al., 1996).
control littermates produced comparable amounts ofThe number of mice used for each group is indicated; 5- to 30-
IFNg. Thereafter, however, the levels of this essentialweek-old mice of both sexes were used. Data are shown as percent
survival calculated from three independent experiments. Both cytokine rapidly declined in Bcl-3-deficient animals,
C57Bl/6 and 129SV genetic background strains are resistant to this while littermate controls continued to produce high lev-
parasite. els (Figure 7A). Initial parasite-induced production of
IFNg in wild-type mice is reported to derive primarily
from activated NK cells, while at later times this cytokine
may be missing in MZs of Bcl-3-deficient animals, al- derives from T. gondii±activated T cells (Gazzinelli et al.,
though a specific loss of the marker protein only cannot 1993; Hunter et al., 1994). Thus, the early rise in IFNg in
yet be ruled out. Taken together, the results indicate a Bcl-3-deficient animals may be due to NK cells, while
general disruption of the MZ architecture in the mutant T cells may never produce this cytokine. Consistent with
mice. this notion, we observed that NK cytolytic activity, a
Finally, red pulp macrophages, which react with the general indicator of NK function, was normal in Bcl-3-
MAC-1, F4/80, or BM-8 antibodies (Leenen et al., 1994), deficient animals (Figure 7C), while T cell±specific pro-
were readily detectable in both wild-type and mutant
duction of IFNg was defective throughout the entire
mice (Figure 5; only F4/80 is shown). However, while
course of infection. Purified, STAg-stimulated splenic T
these cells were present exclusively in the red pulp of
cells of infected, Bcl-3-deficient mice failed to produce
spleens from littermate control animals, they clearly infil-
IFNg at all times, while the T cells of equivalently treated
trated the white pulp of the Bcl-3-deficient spleens (F4/
littermate controls could be shown to produce measur-
80, 2/2; this was observed with the other markers as
able amounts of this cytokine as early as 5 days after
well; data not shown).
infection (Figure 7B). The T cell defect is present regard-
less of whether antigen-presenting cells were derivedInfection with T. gondii
from wild-type or Bcl-3-deficient animals, although theWe investigated for potential defects in T cell±mediated
defect was clearly more pronounced in the latter case.immunity in a physiologically relevant infectious model.
Defective IFNg production by Bcl-3 defective T cells isMice were challenged with T. gondii, an intracellular
not absolute, since stimulation with anti-CD3 antibodiesprotozoan that causes opportunistic infections in AIDS
led to normal induction of this cytokine (Figures 7A andpatients. In wild-type animals, parasites are initially con-
7B). Also, no absolute, cell-autonomous defects couldtrolled by the innate immune response of the host,
be discerned in mitogenic responses of T cells fromthought to be mediated in large part by activated macro-
naive animals (data not shown). Therefore, in vivo anti-phages and natural killer (NK) cells (Gazzinelli et al.,
gen-dependent priming of T cells appeared to be defec-1993). After about 1 week, an antigen-specific, T cell±
tive in the mutant mice, while polyclonal stimulation inmediated immunity begins to dominate, characterized
vitro was normal.by production of helper type 1 cytokines, and the in-
Nitric oxide (NO) directly kills parasites and is inducedfected animals progress from an acute phase to an
in macrophages, at least in part, by IFNg (James, 1995).asymptomatic chronic phase in which parasites are
Consistent with the impaired production of IFNg by Tlargely confined todormant cysts (Gazzinelli etal., 1993).
cells, we noted a significant reduction in the level of NOControl littermates (1/2 and 1/1) generally survived
generated in response to STAg (Figure 7D). This maylonger than 6 months after intraperitoneal injection of T.
contribute to the failure to control the parasite. Further-gondii. In contrast, Bcl-3-deficient mice failed to develop
more, we detected impaired production of interleukin-immunologic resistance and succumbed within a very
12 (IL-12) by splenic cells of infected Bcl-3-deficientnarrow window of 3±5 weeks, with only 1 out of 38
mice (Figure 7E), a cytokine essential for differentiationinfected mutant mice surviving slightly longer (Figure 6).
of T helper 1 cells (Gazzinelli et al., 1993; Trinchieri,Histopathologic examinations revealed that parasites
1995). While the defects in production of NO and IL-12became widely disseminated in Bcl-3-deficient animals
during the course of infection, and this finding correlated could be demonstrated ex vivo with cells derived from
Immunologic Defects in Bcl-3-Deficient Mice
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Figure 7. bcl-3 2/2 Mice Fail to Mount a T
Helper Type 1±like Immune Response to T.
gondii
(A) STAg-induced secretion of IFNg by sple-
nocytes isolated from bcl-3 2/2 mice at
times postinfection as indicated (top panel).
IFNg production is impaired starting 7±12
days after infection with T. gondii. Also shown
are results without stimulation (NS; middle
panel) or with anti-CD3 stimulation (bottom
panel).
(B) Splenic T cells purified from Bcl-3-defi-
cient mice produce reduced amounts of IFNg,
detectable as early as day 5 after infection.
Purity of cells (.97%) was assessed by FCM
analysis using anti-CD3 antibodies (data not
shown). Cells were mixed with antigen-pre-
senting cells (APCs) isolated from infected
bcl-3 2/2 mice (KO) or littermate controls
(WT) and then treated with STAg (top panel)
as in (A), cross-linked with anti-CD3 antibod-
ies (bottom panel), or left untreated (NS; mid-
dle panel).
(C) NK cell cytotoxic activity is not impaired in
bcl-3 2/2 mice. Spleen cells were collected
from mice prior to or 5 days after infection, as
indicated. Comparable results were obtained
also with peritoneal exudate cells (data not
shown). Results are expressed as percent
killing obtained with a 50:1 effector to target
ratio.
(D and E) Reduced production of nitric oxide
(NO) and IL-12/p40 in response to STAg stim-
ulation of splenocytes isolated from infected
bcl-3 2/2 mice at times postinfection as indi-
cated. Bottom panels show data without
stimulation (NS) and top panels with STAg
stimulation. Experiments in (A)±(E) were per-
formed with mice infected in parallel with
those yielding the survival curve of Figure 5, and mice were sacrificed at the indicated times (days after infection). The results are presented
as the means (6 standard deviations) of experimental data from at least three 2/2 mice, matched in each case with one or more littermate
controls (1/2 or 1/1). Data shown were primarily from one set of infected mice. Two other sets of infected mice yielded essentially the same
results. (F) CTL activity against T. gondii is impaired in bcl-3 2/2 mice. Data points were derived from analyses of four mice for each group.
Effector to target cell ratios and calculations are as in (C).
Bcl-3-deficient, infected animals, these defects ap- mice. Bcl-3-deficient mice are impaired in select anti-
gen-specific T and B cell responses, implying a require-peared not to be absolute in macrophages of naive ani-
ment for Bcl-3 in these biologic processes in normalmals, as judged by general stimulation of peritoneal
mice. Infection with the intracellular parasite T. gondiimacrophages in vitro. Thioglycollate-elicited macro-
failed to generate antigen-specific, IFNg-producing Tphages of uninfected, Bcl-3-deficient mice responded
cells in vivo. On the other hand, in vitro stimulation ofnormally with respect to all parameters measured, in-
T cells from Bcl-3 null mice resulted in normal IFNgcluding induced production of NO and IL-12 as well as
production, ruling out an absolute defect in inductionIL-6, tumor necrosis factor a (TNFa), IL-1b, H2O2, or
of IFNg. Instead, a critical defect during in vivo primingsurface expression of Fc receptors and class II antigens
is indicated. The mutant mice were also unable togener-(data not shown).
ate an appropriate IgG2a antibody response againstThe apparent defects in priming of antigen-specific
influenza virus, while IgM responses were normal, asT helper 1 cells may also be responsible for impaired
were circulating levels of all immunoglobulin isotypes.cytotoxic T lymphocyte (CTL) activity against T. gondii±
Consistent with this impaired antibody response to ainfected cells in Bcl-3 null animals (Figure 7F). CTL activ-
T-dependent antigen, Bcl-3 null mice were essentiallyity is an antigen-specific T cell effector function associ-
lacking in germinal center formation, an important ana-ated with host adaptive resistance (Hakim et al., 1991;
tomical site for the generation of high affinity, isotype-Gazzinelli et al., 1993).
switched antibodies against T-dependent antigens. A
disruption of the splenic architecture, and in particular
Discussion the partial or complete loss of macrophage populations
resident in the splenic MZ, could underlie observed de-
We have generated mice which lack functional Bcl-3, fects in antigen-specific priming events in vivo. Finally,
impaired antigen-driven cellular interactions may alsoand we have identified specific biologic defects in these
Immunity
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be involved in the progressive loss of B cells in Bcl-3- like reactions. When challenged with high dose TNP-
KLH adsorbed to alum, these mice generated an appar-deficient animals. Bcl-3 may normally function as an
integral regulator of antigen-dependent cellular signal- ently normal antibody response (unpublished data). In
addition, a few PNA-positive B cell clusters were ob-ing cascades and, as such, may play a role in the survival
of B cells, consistent with its tumorigenic potential. served in spleen under these conditions. Nevertheless,
neither CD35-positive cell clusters nor FDC clusters
were present, confirming the absence of proper germi-
Impaired Adaptive Immunity to T. gondii nal centers. In any event, recent evidence indicates that
Infection of Bcl-3-deficient animals with T. gondii re- antibody responses to T-dependent antigens do not
sulted in death of the animals within 3±5 weeks, while strictly depend on germinal center reactions and may
wild-type or heterozygous littermates survived for longer occur without them, since lymphotoxin a (LTa)-deficient
than 6 months, with few exceptions. This result clearly mice challenged with high dose (but not low dose)
emphasizes the important physiologic role Bcl-3 plays T-dependent antigen generated normal antibody re-
in fighting this pathogen. Extensive analyses of the re- sponses, despite a complete absence of germinal cen-
sponses during the course of infection with T. gondii ters (Matsumoto et al., 1996a).
indicated that the mice specifically failed to establish a
proper antigen-specific T helper 1 response. Production Disruption of the Splenic
of both IL-12 and IFNg were impaired, two cytokines Architecture: The MZ
necessary for generation of a normal T helper1 response
Immunohistochemical analyses of spleen revealed dis-
(Biron and Gazzinelli, 1995; Trinchieri, 1995). IFNg is also
ruptions of the microenvironment, in particular the MZ,
essential for elimination of the parasites (Gazzinelli et
which could underlie at least some of the defects seen
al., 1993), a factwhich is underscored by the rapid death,
in antigen-dependent T and B cell responses in vivo.
at about 9 days, of T. gondii±infected mice rendered
The MZ is a distinct microanatomical site which sur-
null for this cytokine (Scharton-Kersten et al., 1996). Bcl-
rounds the white pulp areas and represents the border
3-deficient animals could be shown to produce some
with the red pulp. It is of special interest since this zone
IFNg from sources other than T cells (most likely NK
is first to encounter and trap blood-borne antigens and
cells) for up to 1±2 weeks postinfection, but not thereaf-
potentially display them for presentation to lymphocytes
ter. An intact early (but transient) innate protection
of the white pulp. The MZ also regulates cellular traffick-
mechanism also explains why Bcl-3-deficient animals
ing into the white pulp, consistent with its strategic bor-
survived for as long as 3±5 weeks, past the initial acute
der location (Liu and Banchereau, 1996). MZs contain
phase of infection. In contrast, the T cell±mediated, anti-
two distinct macrophage populations, marginal metal-
gen-specific helper type 1 response was clearly defec-
lophilic macrophages (MMM), located on the inner por-
tive, and animals succumbed at a time when resistance
tion of the MZ, and marginal zone macrophages (MZM),
depended on antigen-specific T cell functions. It re-
located on the outer portion (Leenen et al., 1994). In Bcl-
mains to be determined whether T helper 2 responses
3-deficient animals, a marker for MZMs could no longer
or T helper 1 responses to other pathogens are impaired
be detected and MMMs were dramatically reduced in
as well.
frequency and formed a disturbed pattern. Thus, a dis-
ruption of the MZ architecture was in evidence, although
markers for MZ endothelial cells (Briskin et al., 1993)Defects in Germinal Center Formation
and reticular fibroblasts (Van Vliet et al., 1986) were stilland Antibody Responses
detected (unpublished data). The inferred functional de-The antibody response to influenza virus was defective.
fects of this border between red and white pulp areLevels of anti-Flu IgG2a, the dominant switched immu-
supported by the abnormal entry into the white pulp ofnoglobulin isotype to this antigen, were significantly re-
macrophages, which normally reside in the red pulpduced. The antibody defect correlated with impaired
only. Taken together, the data imply defects in cellularformation of germinal centers in infected Bcl-3 null mice.
trafficking and possible antigen-presenting functions,In contrast, germinal centers were readily formed in the
defects which may interfere with select critical cellularB cell follicles of littermate controls. Such centers are
interactions necessary for antigen-driven T helper 1 re-the primary anatomical sites where antigen-specific B
sponses to T. gondii and germinal center reactions orcells undergo rapid expansion, coupled with somatic
antibody responses.hypermutations of variable region genes and isotype
switching, followed by selection based on affinity to
antigen, and, finally, differentiation into plasma cells or Mice with Related but Distinct Phenotypes
Disruption of secondary lyphoid microarchitecture ormemory cells (MacLennan, 1994; Kelsoe, 1995). Much
of this biologic program occurs in close proximity with impaired germinal center reaction (or both) has been
observed in several other mice, including mice deficientantigen-specific T helper cells and clustered antigen-
presenting follicular dendritic cells (FDCs) (Tew et al., in LTa (DeTogni et al., 1994; Matsumoto et al., 1996b;
see also Ettinger et al., 1996), TNFa (Pasparakis et al.,1993; Grouard et al., 1995; Kosco-Vilbois and Scheideg-
ger, 1995). 1996), or TNF receptor 1 (LeHir et al., 1996). Loss of
germinal centers has been noted in mice lacking theHowever, Bcl-3-deficient animals were not always
completely blocked in generation of switched antibod- membrane proteins CD40, CD40 ligand (Kawabe et al.,
1994; Xu et al., 1994; Grewal et al., 1995), CD28 (Lane eties to T-dependent antigens, nor did they appear to be
completely blocked in every phase of germinal center± al., 1994; Ferguson et al., 1996), major histocompatibility
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complex class II (Cosgrove et al., 1991), CD19 (Rickert not all) are shared with Bcl-3 null mice. In contrast, the
et al., 1995), or the complement receptors CR1/CR2 phenotypes of p50/p105-deficient mice appear distinct,
(Ahearn et al., 1996); furthermore, the intracellular tyro- including their ability to form germinal centers (unpub-
sine kinase Lyn (Hibbs et al., 1995; Nishizumi et al., 1995) lished data). This lends support to the notion that a
and OBF-1/OCA-B/Bob1, the B cell±specific coactivator physiologically relevant complex of p52 and Bcl-3 exists
of Oct-1 and Oct-2 (Kim et al., 1996; Schubart et al., in vivo, as predicted by previous work in vitro (see Intro-
1996). Of note, CD40- and CD40 ligand±deficient mice duction). The work presented establishes specific and
share several phenotypes with Bcl-3-deficient mice: not physiologically important contexts in which Bcl-3 is re-
only are they impaired in germinal center formation and quired in vivo, which provides a basis to explore these
unable to generate antibodies with switched isotypes biologic processes further, elucidate underlying molec-
to T-dependent antigens, but they also fail to establish ular mechanisms, and define the role of Bcl-3 in tumori-
a T helper 1 phenotype when challenged with leishmania genesis.
(Campbell et al., 1996; Kamanaka et al., 1996; Soong et
al., 1996). Despite this wealth of information, specific
Experimental Proceduresmolecular mechanisms that underlie the observed de-
fects in these mutant mice remain unknown.
Targeted Disruption of the bcl-3 Locus
Mice deficient in the NF-kB proteins p50/p105 (Sha A genomic phage clone carrying ankyrin repeat sequences 1±6 of
et al., 1995; Michaelson et al., 1996; Snapper et al., Bcl-3 was isolated from a 129SV mouse genomic library (Strata-
1996), RelB (Burkly et al., 1995; Weih et al., 1995), c-Rel gene). Two adjoining genomic NotI fragments, Not3 (10.4 kb) and
Not2A (7.2 kb), were obtained from this phage and were cloned into(Kontgen et al., 1995; Gerondakis et al., 1996), and p65
Bluescript SK(2) (BS SK2; Stratagene), partially sequenced, and(Beg et al., 1995a) and in the IkB-a protein (Beg et al.,
mapped for restriction sites (see Figure 1A). To construct the tar-1995b; Klement et al., 1996) have been reported. How-
geting vector, a 4.3 kb NotI±HindIII fragment of BS-Not2A, whichever, none appear to have phenotypes that resemble
carries exons encoding ankyrin 6 and part of ankyrin 5, was inserted
those described here for Bcl-3 null mutants. The results into the BamHI site of the pPNT vector (Tybulewicz et al., 1991),
obtained with these and our mice do suggest that the immediately 39 to the neo gene and 59 to the hsv-tk gene. Subse-
regulatory potential of the NF-kB/IkB system is most quently, the 2.85 kb SmaI fragment derived from BS-Not3 was in-
serted into the XhoI site (just 59 to the neo gene) after filling in byfully utilized by the immune system.
Klenow reaction to generate pPNT-BCL3KO. 50 mg of the targeting
construct (pPNT-BCL3KO) were linearized with NotI and electro-Future Considerations
porated into 107 J1 ES cells (passage 12), as detailed elsewhereThe cells and the gene products most critically affected
(Cao et al., 1995). Positive-negative selection was started 24 hr after
by the absence of Bcl-3 remain to be determined. The transfection using G418 (GIBCO BRL; 350 mg/ml) and ganciclovir (2
presumably complex cellular interactions that are re- mM). Screening of 75 G418/ganciclovir-resistant clones revealed
quired for splenic microarchitecture, germinal center re- six correctly recombined clones (see Figures 1A and 1B for more
details).actions, and/or antigen-specific priming are not under-
stood, and thus the specific role(s) of Bcl-3 cannot yet
be anticipated. It is also unknown whether Bcl-3 is func- FCM Analyses
tionally related to the proteins discussed above that Three-color flow cytometric (FCM) analyses of single cell suspen-
have apparently critical roles in these biologic pro- sions of spleens were performedwith anti-B220-phycoerythrin (PE)-,
anti±CD3-fluorescein isothiocyanate (FITC)- (data not shown), andcesses. It is possible that Bcl-3 carries out important
anti-Thy1.2-biotin-conjugated antibodies (Pharmingen), followed byfunctions in select cells such as MZMs or that it is essen-
streptavidin±red 670 (GIBCO BRL), as previously described (Shorestial in select signaling paths, which may not be readily
et al., 1994).analyzed in vitro. For example, FCM analyses of spleno-
cytes for expression of CD40 and inducible CD40 ligand
Infection with Influenza Virus and Isotypingon T cells (and B7-2 on other cells) appeared grossly
of Antigen-Specific Antibodiesnormal, as did proliferation of purified B cells mediated
We challenged 6- to 19-week-old mice via intranasal injection underthrough signaling via CD40 or IgM (or both), although
metophane anesthesia of 50 ml of a PBS suspension of the A/Philip-
the response was somewhat blunted in the latter case pines influenza strain (250 tissue culture infectious dose50 [TCID50]).
(unpublished data). In any event, such in vitro experi- Mice were rechallenged 22 days later by intraperitoneal injection of
ments cannot rule out subtle yet potentially significant 1 ml of PBS containing approximately 200 hemagglutinating units
defects associated with theseor other signaling proteins (HAU) of the A/PR8 strain. Bleeds were collected on day 27 after
initial infection, and preimmune sera were harvested 24 hr beforein Bcl-3-deficient animals.
primary challenge. Titer of antibodies to influenza virus were deter-The function(s) Bcl-3 executes in building or main-
mined by isotype-specific enzyme-linked immunosorbent assaytaining the microarchitecture of secondary lymphoid or-
(ELISA). We coated 96-well plates (Nunc) overnight at 48C with for-
gans may be required for at least some T helper 1 re- malin-inactivated influenza vaccine, A/Philippines. After blocking
sponses and some T-dependent antibody responses. (1% fetal calf serum, 0.05% sodium azide in PBS) and between
Furthermore, survival of B cells may depend on these subsequent steps, plates were washed four times with PBS-T
same or similar functions. In the absence of Bcl-3, B cells (0.05% Tween 20, 0.05% sodium azide in PBS). Serial dilutions of
sera were then transferred onto virus-coated plates and incubatedappeared less well organized in secondary lymphoid
for 2 hr. Alkaline phosphatase±conjugated goat antibodies to vari-organs and their numbers were reduced. The implied
ous mouse immunoglobulin isotypes (Southern Biotechnology As-role of Bcl-3 in B cell survival may explain its oncogenic
sociates) were added to washed plates and incubated for 1 hr.
activity when expressed at high, constitutive levels as Plates were finally washed and substrate was added (1 mg/ml
a result of chromosomal translocation. Preliminary anal- p-nitrophenyl phosphate in 1 mM MgCl2, 50 mM Na-bicarbonate
yses of p52/p100-deficient animals generated inour lab- buffer [pH 9.8]). Optical density was measured with a Titertek
MultiScan ELISA plate reader at 414 nm.oratory so far suggest that a number of phenotypes (but
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Immunoperoxidase Staining of Paraffin-Embedded 1.5 3 106 T cells from individual mice in 24-well plates in 800 ml of
and Frozen Tissue Sections medium with 5 3 106 antigen-presenting cells pooled from spleens
Lymph nodes and spleens were fixed in Bouin's fixative for 24 hr, of bcl-3 2/2 (knockout) or 1/1 and 1/2 (wild type) mice, as indi-
rinsed, and transferred into 70% ethanol. Tissues were then pro- cated. Cells were treated as specified and IFNg was measured 72
cessed through alcohols and xylene, embedded in paraffin, sec- hr later, as described above.
tioned at 5 mm and either stained with hematoxylin and eosin or
used for immunohistochemistry. Sections were stained with an anti- Cytotoxicity Assays
human CD3 rabbit polyclonal antibody (Dako Corporation) or an NK cell±mediated lysing of target cells was carried out as described
anti-mouse B220/CD45R biotin-conjugated rat monoclonal anti- (Scharton-Kersten et al., 1996) with effector spleen cells obtained
body (Boehringer-Mannheim). An anti-rabbit biotin-conjugated sec- from mice prior to or 5 days after infection with T. gondii. For the
ondary antibody was subsequently used for the CD3 stain (Vector CTL assays, mice were immunized by intraperitoneal inoculation of
Laboratories). Slides were then incubated with streptavidin-conju- 2 3 104 live tachyzoites of the ts-4 strain of T. gondii (Hakim et al.,
gated horseradish peroxidase (HRP), and the avidin±biotin com- 1991) and boosted after 15 and 30 days with the same dose. CTL
plexes were revealed with 3,39-diaminobenzidine (DAB) tetrahydro- activity against T. gondii was measured in single spleen cell suspen-
chloride chromogen (Sigma).
sions 6 weeks after the last boost, as detailed elsewhere (Hakim et
For frozen sections, spleens were extracted, placed in OCT freez-
al., 1991). In brief, responder cells (5 3 106) from vaccinated miceing medium (Miles Laboratories, Inc.), and flash frozen. Acetone-
were cultured in 2 ml in 24-well plates with 106 g-irradiated (15,000fixed sections (10 mm) were stained as described previously (Kelsall
rads) ts-4 tachyzoites for 5 days. The presence of a similar percent-and Strober, 1996). In brief, tissue sections were rehydrated in phos-
age of CD81 cells in the different cultures was assessed by FCMphate-buffered saline (PBS) containing 0.1% BSA (fraction V, PBS/
analyses performed just before the assay. Resident peritoneal mac-BSA; Sigma) and then blocked for 30 min with 20% normal mouse
rophages from C57Bl/6 mice were infected with the RH strain of T.serum and 20% goat or rabbit serum (same species as secondary
gondii and used as target cells. Uninfected macrophages were alsoantibody) in PBS (PBS/serum). After blocking, sections were incu-
used to calculate the specific 51Cr release. For both NK and CTLbated for 60 min with the primary antibody prepared in PBS/serum,
activity, effector to target ratios were 100:1, 50:1, 25:1, and 12:1.washed in PBS/BSA, and then incubated for an additional 30 min
The specific 51Cr release into supernatants (percent killing) was cal-with the biotinylated secondary antibody in PBS/serum (except for
culated from the effector:target ratio of 50:1 as follows: [(experimen-those stained with biotinylated PNA or biotinylated anti-CD35 anti-
tal release 2 spontaneous release)/(maximum release 2 spontane-bodies). After quenching endogenous peroxidase activity, tissue
ous release)] 3 100%. Maximum and spontaneous 51Cr releasesections were incubated for 30 min with streptavidin-conjugated
values were calculated by adding 10% sodium dodecyl sulfate (SDS;HRP (Vector Laboratories) and washed in PBS/BSA, and the avidin±
Sigma) or medium alone, respectively, in place of effector cells.biotin complexes were revealed with the DAB chromogen (Vector
Laboratories), according to the instructions of the manufacturer.
Finally, slides were rinsed, counterstained with methyl green (Vector Acknowledgments
Laboratories), and permanently mounted with Permount (Fisher Sci-
entific). Sources of reagents were as follows: biotinylated PNA Correspondence should be addressed to U. S. We thank A. S. Fauci,
(Pierce); FDC-M1 (anti-FDCs; a gift of Drs. M. H. Kosco-Vilbois and K. Kelly, and R. Hodes for review of the manuscript and A. S. Fauci
G. Burton); biotinylated anti-CD35 (Pharmingen); F4/80 (anti±red for continued support. We are grateful to J. Bennick for help and
pulp macrophage; Caltag Laboratories); MOMA-1 (anti-marginal advice with influenza virus infections; E. Denkers for help with the
metallophilic macrophages; BACHEM Bioscience Inc.); ER TR-9 CTL assay; R. Nangia and G. Sayer for help with ELISAs; J. A.
(anti-marginal zone macrophages; BACHEM Bioscience Inc.). Williams for help with macrophages;A. Anderson for help with analy-
sis of lymph node sections; M. H. Kosco-Vilbois and G. Burton for
Cell Culture, Stimulations, and the FDC-M1 reagent; and M. Rust for help with the preparation of
Cytokine Measurements this manuscript. We are deeply indebted to H. Westphal for use of
Single cell suspensions wereprepared from spleens and, after lysing his facilities in generating the knockout mice.
of erythrocytes, cells were washed and cultured at 378C in RPMI
medium (Scharton-Kersten et al., 1996). For Figures 7A, 7D, and 7E, Received December 18, 1996; revised February 6, 1997.
cells were cultured in 24-well plates (5 3 106 cells per well) in a total
volume of 1 ml and treated with STAg (5 mg/ml) (Hakim et al., 1991)
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